Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-20

FDA Approved: FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for Fosinopril sodium and hydrochlorothiazide from Aurobindo Pharma Limited. The approval covers a generic combinati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosinopril Sodium and Hydrochlorothiazide (fosinopril sodium and hydrochlorothiazide)

Snippet

SUPPL AP for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE (FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE)